1 Min Read
May 1 (Reuters) - Highbridge Capital Management:
* Highbridge Capital Management reports 5.39 pct passive stake in Novelion Therapeutics Inc as of April 19 - SEC filing Source text: (bit.ly/2qxg3am) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.